Healthcare providers as sources of vaccine-preventable diseases

Vaccine

Volumn 32, Issue 38, 2014, Pages 4814-4822

  Sydnor, Emily ^a   Perl, Trish M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Healthcare provider; Infection control and prevention; Vaccine preventable infectious diseases

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; VARICELLA ZOSTER VACCINE;

DIPHTHERIA; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HERPES ZOSTER; HUMAN; INFECTION CONTROL; INFLUENZA; MEASLES; MUMPS; NONHUMAN; PATIENT CARE; PERTUSSIS; PRIORITY JOURNAL; REVIEW; RUBELLA; TETANUS; VACCINATION; VIRUS TRANSMISSION; CROSS INFECTION; DISEASE TRANSMISSION; INFLUENZA, HUMAN; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION; WHOOPING COUGH;

COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; HEALTH PERSONNEL; HEPATITIS B; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; INFLUENZA, HUMAN; MEASLES; MUMPS; RUBELLA; VACCINATION; WHOOPING COUGH;

EID: 84906068892     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.097     Document Type: Review

References (174)

1. The Henry J. Kaiser Family Foundation. n.d.
2. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60:1-45.
3. Carey W.D. The prevalence and natural history of hepatitis B in the 21st century. Cleve Clin J Med 2009, 76(Suppl. 3):S2-S5.
4. McQuillan G.M., Coleman P.J., Kruszon-Moran D., Moyer L.A., Lambert S.B., Margolis H.S. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999, 89:14-18.
5. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
6. Johnston B.L., MacDonald S., Lee S., LeBlanc J.C., Gross M., Schlech W.F., et al. Nosocomial hepatitis B associated with orthopedic surgery - Nova Scotia. Can Commun Dis Rep 1992, 18:89-90.
7. Enfield K.B., Sharapov U., Hall K.K., Leiner J., Berg C.L., Xia G-L., et al. Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load. Clin Infect Dis 2013, 56:218-224.
8. Puro V., Scognamiglio P., Ippolito G. [HIV, HBV, or HDV transmission from infected health care workers to patients]. Med Lav 2003, 94:556-568.
9. Bell D.M., Shapiro C.N., Ciesielski C.A., Chamberland M.E. Preventing bloodborne pathogen transmission from health-care workers to patients. The CDC perspective. Surg Clin North Am 1995, 75:1189-1203.
10. Spijkerman I.J.B., van Doorn L-J., Janssen M.H.W., Wijkmans C.J., Bilkert-Mooiman M.A.J., Coutinho R.A., et al. Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years. Infect Control Hosp Epidemiol 2002, 23:306-312.
11. Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff. CDR (Lond Engl Rev) 1991, 1:R81-R85.
12. Harpaz R., Seidlein Von L., Averhoff F.M., Tormey M.P., Sinha S.D., Kotsopoulou K., et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996, 334:549-554.
13. Sundkvist T., Hamilton G.R., Rimmer D., Evans B.G., Teo C.G. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1998, 1:48-50.
14. Teams T.I.I. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. The Incident Investigation Teams and others. N Engl J Med 1997, 336:178-184.
15. Heptonstall J. Lessons from two linked clusters of acute hepatitis B in cardiothoracic surgery patients. Commun Dis Rep CDR Rev 1996, 6:R119-R125.
16. Laurenson I.F., Jones D.G., Hallam N.F., Saunders C.J.P., Fraser D.M., Carman W.F. Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect 2007, 66:393-394.
17. Molyneaux P., Reid T.M., Collacott I., McIntyre P.G., Dillon J.F., Laing R.B. Acute hepatitis B in two patients transmitted from an e antigen negative cardiothoracic surgeon. Commun Dis Public Health 2000, 3:250-252.
18. Hepatitis B Outbreak Investigation Team An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. Can Med Assoc J 2000, 162:1127-1131.
19. Oliver S.E., Woodhouse J., Hollyoak V. Lessons from patient notification exercises following the identification of hepatitis B e antigen positive surgeons in an English health region. Commun Dis Public Health 1999, 2:130-136.
20. Snydman D.R., Hindman S.H., Wineland M.D., Bryan J.A., Maynard J.E. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients. Ann Intern Med 1976, 85:573-577.
21. Coutinho R.A., Albrecht-van Lent P., Stoutjesdijk L., Meerburg-Snarenberg P., Couroucé-Pauty A.M., van Dijk B.A., et al. Hepatitis B from doctors. Lancet 1982, 1:345-346.
22. Grob P.J., Bischof B., Naeff F. Cluster of hepatitis B transmitted by a physician. Lancet 1981, 2:1218-1220.
23. Holmberg S.D., Suryaprasad A., Ward J.W. Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR Recomm Rep 2012, 1-12.
24. Corden S., Ballard A.L., Ijaz S., Barbara J.A.J., Gilbert N., Gilson R.J.C., et al. HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol 2003, 27:52-58.
25. Centers for Disease Control and Prevention (CDC) Hepatitis B vaccination - United States, 1982-2002. MMWR Morb Mortal Wkly Rep 2002, 51. 549-52-563.
26. Public Health Agency of Canada. Canadian Immunization Guide. n.d.
27. Gunson R.N., Shouval D., Roggendorf M., Zaaijer H., Nicholas H., Holzmann H., et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003, 27:213-230.
28. Health DO. Hepatitis B 2009:1-24.
29. Occupational exposure to bloodborne pathogens - OSHA: final rule. Fed Regist 1991, 56:64004-64182.
30. Henderson D.K., Dembry L., Fishman N.O., Grady C., Lundstrom T., Palmore T.N., et al. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol 2010, 31:203-232.
31. Centers for Disease Control and Prevention (CDC) Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010, 59:1057-1062.
32. World Health Organization, editor. Influenza Fact Sheet. n.d.
33. Molinari N-A.M., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
34. Brankston G., Gitterman L., Hirji Z., Lemieux C., Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007, 7:257-265.
35. Mubareka S., Lowen A.C., Steel J., Coates A.L., García-Sastre A., Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009, 199:858-865.
36. Klimov A.I., Rocha E., Hayden F.G., Shult P.A., Roumillat L.F., Cox N.J. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995, 172:1352-1355.
37. Munoz F.M., Campbell J.R., Atmar R.L., Garcia-Prats J., Baxter B.D., Johnson L.E., et al. Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 1999, 18:811-815.
38. Leekha S., Zitterkopf N.L., Espy M.J., Smith T.F., Thompson R.L., Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007, 28:1071-1076.
39. Bean B., Moore B.M., Sterner B., Peterson L.R., Gerding D.N., Balfour H.H. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982, 146:47-51.
40. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
41. Rojo J.C., Ruiz-Contreras J., Fernández M.B., Marín M.A., Folgueira L. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J 2006, 25:596-601.
42. Maltezou H.C. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008, 21:337-343.
43. Maltezou H.C., Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003, 55:83-91.
44. Foy H.M., Cooney M.K., Allan I.D., Albrecht J.K. Influenza B in households: virus shedding without symptoms or antibody response. Am J Epidemiol 1987, 126:506-515.
45. Weingarten S., Riedinger M., Bolton L.B., Miles P., Ault M. Barriers to influenza vaccine acceptance: a survey of physicians and nurses. Am J Infect Control 1989, 17:202-207.
46. Jena A.B., Baldwin D.C., Daugherty S.R., Meltzer D.O., Arora V.M. Presenteeism among resident physicians. J Am Med Assoc 2010, 304:1166-1168.
47. Meibalane R., Sedmak G.V., Sasidharan P., Garg P., Grausz J.P. Outbreak of influenza in a neonatal intensive care unit. J Pediatr 1977, 91:974-976.
48. Wenzel R.P., Deal E.C., Hendley J.O. Hospital-acquired viral respiratory illness on a pediatric ward. Pediatrics 1977, 60:367-371.
49. Salgado C.D., Farr B.M., Hall K.K., Hayden F.G. Influenza in the acute hospital setting. Lancet Infect Dis 2002, 2:145-155.
50. Sagrera X., Ginovart G., Raspall F., Rabella N., Sala P., Sierra M., et al. Outbreaks of influenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J 2002, 21:196-200.
51. Kawana A., Teruya K., Kirikae T., Sekiguchi J-I., Kato Y., Kuroda E., et al. Syndromic surveillance within a hospital for the early detection of a nosocomial outbreak of acute respiratory infection. Jpn J Infect Dis 2006, 59:377-379.
52. Outbreak Database. n.d.
53. Meara M.O., Brien A.O., Feely E., Conlon M. Influenza A outbreak in a community hospital. Ir Med J 2006, 99:175-177.
54. Sartor C., Zandotti C., Romain F., Jacomo V., Simon S., Atlan-Gepner C., et al. Disruption of services in an internal medicine unit due to a nosocomial influenza outbreak. Infect Control Hosp Epidemiol 2002, 23:615-619.
55. Hansen S., Stamm-Balderjahn S., Zuschneid I., Behnke M., Rüden H., Vonberg R-P., et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 2007, 65:348-353.
56. Hammond G.W., Cheang M. Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J 1984, 131:449-452.
57. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
58. Saxén H., Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J 1999, 18:779-783.
59. Wilde J.A., McMillan J.A., Serwint J., Butta J., O'Riordan M.A., Steinhoff M.C. Effectiveness of influenza vaccine in health care professionals: a randomized trial. J Am Med Assoc 1999, 281:908-913.
60. Potter J., Stott D.J., Roberts M.A., Elder A.G., O'Donnell B., Knight P.V., et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997, 175:1-6.
61. Hayward A.C., Harling R., Wetten S., Johnson A.M., Munro S., Smedley J., et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. Br Med J 2006, 333:1241.
62. Lemaitre M., Meret T., Rothan-Tondeur M., Belmin J., Lejonc J-L., Luquel L., et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 2009, 57:1580-1586.
63. Carman W.F., Elder A.G., Wallace L.A., McAulay K., Walker A., Murray G.D., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000, 355:93-97.
64. Jefferson T., Di Pietrantonj C., Al-Ansary L.A., Ferroni E., Thorning S., Thomas R.E. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, CD004876.
65. Thomas R.E., Jefferson T., Lasserson T.J. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2013, 7:CD005187.
66. Zimmerman R.K. Ethical analyses of institutional measures to increase health care worker influenza vaccination rates. Vaccine 2013, 31:6172-6176.
67. Stewart A.M. Mandatory vaccination of health care workers. N Engl J Med 2009, 361:2015-2017.
68. Ottenberg A.L., Wu J.T., Poland G.A., Jacobson R.M., Koenig B.A., Tilburt J.C. Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate. Am J Public Health 2011, 101:212-216.
69. Caplan A. Time to mandate influenza vaccination in health-care workers. Lancet 2011, 378:310-311.
70. Talbot T.R., Babcock H., Caplan A.L., Cotton D., Maragakis L.L., Poland G.A., et al. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol 2010, 31:987-995.
71. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010, 59:1-62.
72. Siegel J.D., Rhinehart E., Jackson M., Chiarello L., Health Care Infection Control Practices Advisory Committee 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 35:S65-S164.
73. Centers for Disease Control and Prevention (CDC) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013, 62:1-43.
74. FDA News Release. n.d.
75. Centers for Medicare and Medicaid Services (CMS), HHS Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules. Fed Regist 2011, 76:51476-51846.
76. Bull A.L., Bennett N., Pitcher H.C., Russo P.L., Richards M.J. Influenza vaccine coverage among health care workers in Victorian public hospitals. Med J Aust 2007, 186:185-186.
77. Walker F.J., Singleton J.A., Lu P., Wooten K.G., Strikas R.A. Influenza vaccination of healthcare workers in the United States, 1989-2002. Infect Control Hosp Epidemiol 2006, 27:257-265.
78. CDC, editor. Adult Vaccination Coverage. n.d.
79. Bautista D., Vila B., Uso R., Tellez M., Zanon V. Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers. Infect Control Hosp Epidemiol 2006, 27:73-77.
80. Piccirillo B., Gaeta T. Survey on use of and attitudes toward influenza vaccination among emergency department staff in a New York metropolitan hospital. Infect Control Hosp Epidemiol 2006, 27:618-622.
81. Dunais B., Saccomano C., Mousnier A., Roure M-C., Dellamonica P., Roger P-M. Influenza vaccination: impact of an intervention campaign targeting hospital staff. Infect Control Hosp Epidemiol 2006, 27:529-531.
82. Talbot T.R. Do declination statements increase health care worker influenza vaccination rates?. Clin Infect Dis 2009, 49:773-779.
83. Pavia A.T. Mandate to protect patients from health care-associated influenza. Clin Infect Dis 2010, 50:465-467.
84. Ajenjo M.C., Woeltje K.F., Babcock H.M., Gemeinhart N., Jones M., Fraser V.J. Influenza vaccination among healthcare workers: ten-year experience of a large healthcare organization. Infect Control Hosp Epidemiol 2010, 31:233-240.
85. Polgreen P.M., Septimus E.J., Parry M.F., Beekmann S.E., Cavanaugh J.E., Srinivasan A., et al. Relationship of influenza vaccination declination statements and influenza vaccination rates for healthcare workers in 22 US hospitals. Infect Control Hosp Epidemiol 2008, 29:675-677.
86. Rakita R.M., Hagar B.A., Crome P., Lammert J.K. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect Control Hosp Epidemiol 2010, 31:881-888.
87. Palmore T.N., Vandersluis J.P., Morris J., Michelin A., Ruprecht L.M., Schmitt J.M., et al. A successful mandatory influenza vaccination campaign using an innovative electronic tracking system. Infect Control Hosp Epidemiol 2009, 30:1137-1142.
88. Babcock H.M., Gemeinhart N., Jones M., Dunagan W.C., Woeltje K.F. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis 2010, 50:459-464.
89. Feemster K.A., Prasad P., Smith M.J., Feudtner C., Caplan A., Offit P., et al. Employee designation and health care worker support of an influenza vaccine mandate at a large pediatric tertiary care hospital. Vaccine 2011, 29:1762-1769.
90. Karanfil L.V., Bahner J., Hovatter J., Thomas W.L. Championing patient safety through mandatory influenza vaccination for all healthcare personnel and affiliated physicians. Infect Control Hosp Epidemiol 2011, 32:375-379.
91. Septimus E.J., Perlin J.B., Cormier S.B., Moody J.A., Hickok J.D. A multifaceted mandatory patient safety program and seasonal influenza vaccination of health care workers in community hospitals. J Am Med Assoc 2011, 305:999-1000.
92. Buchanan R., Bonthius D.J. Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 2012, 19:107-114.
93. LANGMUIR A.D. Medical importance of measles. Am J Dis Child 1962, 103:224-226.
94. Bloch A.B., Orenstein W.A., Stetler H.C., Wassilak S.G., Amler R.W., Bart K.J., et al. Health impact of measles vaccination in the United States. Pediatrics 1985, 76:524-532.
95. Orenstein W.A., Papania M.J., Wharton M.E. Measles elimination in the United States. J Infect Dis 2004, 189(Suppl. 1):S1-S3.
96. World Health Organization, editor. Measles Fact Sheet. n.d.
97. Steingart K.R., Thomas A.R., Dykewicz C.A., Redd S.C. Transmission of measles virus in healthcare settings during a communitywide outbreak. Infect Control Hosp Epidemiol 1999, 20:115-119.
98. Parker A.A., Staggs W., Dayan G.H., Ortega-Sanchez I.R., Rota P.A., Lowe L., et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 2006, 355:447-455.
99. Chen S.Y., Anderson S., Kutty P.K., Lugo F., McDonald M., Rota P.A., et al. Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis 2011, 203:1517-1525.
100. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., Phillips L. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998, 47:1-57.
101. Gupta R.K., Best J., MacMahon E. Mumps and the UK. Epidemic 2005. Br Med J 2005, 330:1132-1135.
102. Wharton M., Cochi S.L., Hutcheson R.H., Schaffner W. Mumps transmission in hospitals. Arch Intern Med 1990, 150:47-49.
103. Fischer P.R., Brunetti C., Welch V., Christenson J.C. Nosocomial mumps: report of an outbreak and its control. Am J Infect Control 1996, 24:13-18.
104. Bonebrake A.L., Silkaitis C., Monga G., Galat A., Anderson J., Trad J.T., et al. Effects of mumps outbreak in hospital, Chicago, Illinois, USA, 2006. Emerg Infect Dis 2010, 16:426-432.
105. Harris R.W., Kehrer A.F., Isacson P. Relationship of occupations to risk of clinical mumps in adults. Am J Epidemiol 1969, 89:264-270.
106. Centers for Disease Control and Prevention (CDC) Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010, 59:125-129.
107. GORDON J.E., KILHAM L. Ten years in the epidemiology of mumps. Am J Med Sci 1949, 218:338-359.
108. PHILIP R.N., REINHARD K.R., LACKMAN D.B. Observations on a mumps epidemic in a virgin population. Am J Hyg 1959, 69:91-111.
109. MEYER M.B. An epidemiologic study of mumps: its spread in schools and families. Am J Hyg 1962, 75:259-281.
110. Buynak E.B., Hilleman M.R. Live attenuated mumps virus vaccine: 1. Vaccine development. Proc Soc Exp Biol Med 1966, 123:768-775.
111. van Loon F.P., Holmes S.J., Sirotkin B.I., Williams W.W., Cochi S.L., Hadler S.C., et al. Mumps surveillance - United States, 1988-1993. MMWR CDC Surveill Summ 1995, 44:1-14.
112. Centers for Disease Control and Prevention (CDC) National and state vaccination coverage among adolescents aged 13 through 17 years - United States, 2010. MMWR Morb Mortal Wkly Rep 2011, 60:1117-1123.
113. CDC, editor. Coverage estimates for school entry vaccinations for school year 2009-2010. n.d.
114. Centers for Disease Control and Prevention (CDC) Brief report: update: mumps activity - United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep 2006, 55:1152-1153.
115. Centers for Disease Control and Prevention (CDC) Mumps epidemic - Iowa. MMWR Morb Mortal Wkly Rep 2006, 55:366-368.
116. Centers for Disease Control and Prevention (CDC) Mumps outbreak on a university campus - California, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:986-989.
117. Best J.M. Rubella. Semin Fetal Neonatal Med 2007, 12:182-192.
118. McLaughlin M.C., Gold L.H. The New York rubella incident: a case for changing hospital policy regarding rubella testing and immunization. Am J Public Health 1979, 69:287-289.
119. Polk B.F., White J.A., DeGirolami P.C., Modlin J.F. An outbreak of rubella among hospital personnel. N Engl J Med 1980, 303:541-545.
120. Gladstone J.L., Millian S.J. Rubella exposure in an obstetric clinic. Obstet Gynecol 1981, 57:182-186.
121. Centers for Disease Control (CDC) Nosocomial rubella infection - North Dakota, Alabama, Ohio. MMWR Morb Mortal Wkly Rep 1981, 29:630-631.
122. Strassburg M.A., Imagawa D.T., Fannin S.L., Turner J.A., Chow A.W., Murray R.A., et al. Rubella outbreak among hospital employees. Obstet Gynecol 1981, 57:283-288.
123. Fliegel P.E., Weinstein W.M. Rubella outbreak in a prenatal clinic: management and prevention. Am J Infect Control 1982, 10:29-33.
124. Heseltine P.N., Ripper M., Wohlford P. Nosocomial rubella - consequences of an outbreak and efficacy of a mandatory immunization program. Infect Control 1985, 6:371-374.
125. Centers for Disease Control and Prevention (CDC) Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep 2005, 54:279-282.
126. Reef S.E., Cochi S.L. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis 2006, 43(Suppl. 3):S123-S125.
127. Aksit S., Egemen A., Ozacar T., Kurugol Z., Keskinoglu P., Tasbakan M., et al. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr Infect Dis J 1999, 18:577-580.
128. Centers for Disease Control and Prevention (CDC) Progress toward elimination of measles and prevention of congenital rubella infection - European region, 1990-2004. MMWR Morb Mortal Wkly Rep 2005, 54:175-178.
129. Onyenekwe C.C., Kehinde-Agbeyangi T.A., Ofor U.S., Arinola O.G. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. West Afr J Med 2000, 19:23-26.
130. Marin M., Quinlisk P., Shimabukuro T., Sawhney C., Brown C., Lebaron C.W. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine 2008, 26:3601-3607.
131. Strebel P.M., Parania M.J., Dayan G.H., Halsey N.A. Measles vaccine. Vaccines 2008, 353-398. Elsevier Inc., Philadelphia, PA. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
132. Lievano F., Galea S.A., Thornton M., Wiedmann R.T., Manoff S.B., Tran T.N., et al. Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience. Vaccine 2012, 30:6918-6926.
133. Weber D.J., Rutala W.A., Schaffner W. Lessons learned: protection of healthcare workers from infectious disease risks. Crit Care Med 2010, 38:S306-S314.
134. Watkins N.M., Smith R.P., St Germain D.L., MacKay D.N. Measles (rubeola) infection in a hospital setting. Am J Infect Control 1987, 15:201-206.
135. Braunstein H., Thomas S., Ito R. Immunity to measles in a large population of varying age: significance with respect to vaccination. Am J Dis Child 1990, 144:296-298.
136. Smith E., Wong V.K. Measles susceptibility of hospital personnel. Arch Intern Med 1993, 153:1011.
137. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18:326-382.
138. Heininger U., Cherry J.D., Stehr K., Schmitt-Grohé S., Uberall M., Laussucq S., et al. Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (D0TaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group. Pediatrics 1998, 102:546-553.
139. CDC, editor. Pertussis Outbreak Trends. n.d.
140. Kretsinger K., Broder K.R., Cortese M.M., Joyce M.P., Ortega-Sanchez I., Lee G.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55:1-37.
141. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012, 61:468-470.
142. Kurt T.L., Yeager A.S., Guenette S., Dunlop S. Spread of pertussis by hospital staff. J Am Med Assoc 1972, 221:264-267.
143. Linnemann C.C., Ramundo N., Perlstein P.H., Minton S.D., Englender G.S. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975, 2:540-543.
144. Valenti W.M., Pincus P.H., Messner M.K. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980, 134:520-521.
145. Christie C.D., Glover A.M., Willke M.J., Marx M.L., Reising S.F., Hutchinson N.M. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995, 16:556-563.
146. Bolyard E.A., Tablan O.C., Williams W.W., Pearson M.L., Shapiro C.N., Deitchmann S.D. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998, 19:407-463.
147. Goins W.P., Edwards K.M., Vnencak-Jones C.L., Rock M.T., Swift M., Thayer V., et al. A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel. Clin Infect Dis 2012, 54:938-945.
148. Straus S.E., Ostrove J.M., Inchauspé G., Felser J.M., Freifeld A., Croen K.D., et al. NIH conference. Varicella-zoster virus infections: biology, natural history, treatment, and prevention. Ann Intern Med 1988, 108:221-237.
149. Marin M., Güris D., Chaves S.S., Schmid S., Seward J.F., Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56:1-40.
150. Gnann J.W., Whitley R.J. Clinical practice. Herpes zoster. N Engl J Med 2002, 347:340-346.
151. McDonald J.R., Zeringue A.L., Caplan L., Ranganathan P., Xian H., Burroughs T.E., et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009, 48:1364-1371.
152. Meyers J.D., MacQuarrie M.B., Merigan T.C., Jennison M.H. Nosocomial varicella: Part I. Outbreak in oncology patients at a children's hospital. West J Med 1979, 130:196-199.
153. Asano Y., Iwayama S., Miyata T., Yazaki T., Ozaki T., Tsuzuki K., et al. Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 1980, 23:157-161.
154. Gustafson T.L., Shehab Z., Brunell P.A. Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child 1984, 138:548-550.
155. Gustafson T.L., Lavely G.B., Brawner E.R., Hutcheson R.H., Wright P.F., Schaffner W. An outbreak of airborne nosocomial varicella. Pediatrics 1982, 70:550-556.
156. Hyams P.J., Stuewe M.C., Heitzer V. Herpes zoster causing varicella (chickenpox) in hospital employees: cost of a casual attitude. Am J Infect Control 1984, 12:2-5.
157. Weitekamp M.R., Schan P., Aber R.C. An algorithm for the control of nosocomial varicella-zoster virus infection. Am J Infect Control 1985, 13:193-198.
158. Alter S.J., Hammond J.A., McVey C.J., Myers M.G. Susceptibility to varicella-zoster virus among adults at high risk for exposure. Infect Control 1986, 7:448-451.
159. Krasinski K., Holzman R.S., LaCouture R., Florman A. Hospital experience with varicella-zoster virus. Infect Control 1986, 7:312-316.
160. Weber D.J., Rutala W.A., Parham C. Impact and costs of varicella prevention in a university hospital. Am J Public Health 1988, 78:19-23.
161. Leclair J.M., Zaia J.A., Levin M.J., Congdon R.G., Goldmann D.A. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980, 302:450-453.
162. Josephson A., Gombert M.E. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988, 158:238-241.
163. Sawyer M.H., Chamberlin C.J., Wu Y.N., Aintablian N., Wallace M.R. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 1994, 169:91-94.
164. Behrman A., Schmid D.S., Crivaro A., Watson B. A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers. Infect Control Hosp Epidemiol 2003, 24:202-206.
165. Adler A.L., Casper C., Boeckh M., Heath J., Zerr D.M. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 2008, 29:866-870.
166. Lopez A.S., Burnett-Hartman A., Nambiar R., Ritz L., Owens P., Loparev V.N., et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008, 197:646-653.
167. Friedman C.A., Temple D.M., Robbins K.K., Rawson J.E., Wilson J.P., Feldman S. Outbreak and control of varicella in a neonatal intensive care unit. Pediatr Infect Dis J 1994, 13:152-154.
168. Faoagali J.L., Darcy D. Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control. Am J Infect Control 1995, 23:247-250.
169. Haiduven-Griffiths D., Fecko H. Varicella in hospital personnel: a challenge for the infection control practitioner. Am J Infect Control 1987, 15:207-211.
170. Gershon A.A., Steinberg S.P., LaRussa P., Ferrara A., Hammerschlag M., Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988, 158:132-137.
171. Kuter B.J., Ngai A., Patterson C.M., Staehle B.O., Cho I., Matthews H., et al. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine 1995, 13:967-972.
172. Güris D., Jumaan A.O., Mascola L., Watson B.M., Zhang J.X., Chaves S.S., et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis 2008, 197(Suppl. 2):S71-S75.
173. Lopez A.S., Zhang J., Brown C., Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics 2011, 127:238-245.
174. Marin M., Zhang J.X., Seward J.F. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011, 128:214-220.